Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 16/20 | 0.71 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.61 |
| ▸ | FFAR4 | Q5NUL3 | 5/20 | 0.60 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2349792 | 0.91 | FFAR1 (0.58) | FFAR1SRD5A2FFAR4 | |
| SCHEMBL2353782 | 0.84 | SRD5A2 (0.59) | SRD5A2 | |
| SCHEMBL2774842 | 0.83 | FFAR1 (1.00) | FFAR1SRD5A2FFAR4KEAP1 | |
| SCHEMBL8623496 | 0.83 | FFAR1 (0.71) | FFAR1SRD5A2FFAR4KEAP1 | |
| SCHEMBL30644928 | 0.83 | FFAR1 (0.69) | FFAR1SRD5A2FFAR4 | |
| SCHEMBL1271028 | 0.81 | FFAR4 (0.58) | FFAR1FFAR4 | |
| Apteniol A SCHEMBL16431559 | 0.81 | FFAR1 (0.89) | FFAR1SRD5A2FFAR4KEAP1 | |
| SCHEMBL1271014 | 0.80 | FFAR4 (0.68) | FFAR1FFAR4 | |
| SCHEMBL3992963 | 0.79 | FFAR4 (0.78) | FFAR1SRD5A2FFAR4 | |
| SCHEMBL5926621 | 0.79 | FFAR1 (0.90) | FFAR1SRD5A2FFAR4KEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8476399-B2 | Biocompatible polymers for medical devices | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2013-07-02 | — | — | US | disclosed |
| US-20130085238-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2013-04-04 | — | — | US | disclosed |
| US-8252887-B2 | Biocompatible polymers for medical devices | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2012-08-28 | — | — | US | disclosed |
| US-20100234555-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | RUTGERS, THE STATE UNIVERSITY (US) | 2010-09-16 | — | — | US | disclosed |
| WO-2010042918-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2010-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234555-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | ECPAS, PTGIR, RXFP1 | FFAR1 827/4885SRD5A2 4701/4885FFAR4 1951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.